WIP
ABBV icon

WealthCare Investment Partners’s AbbVie ABBV Stock Holding History

WealthCare Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
2,020
+8
+0.4% +$1.72K 0.12% 126
2026
Q1 		$417K Buy
2,012
+1,007
+100% +$223K 0.12% 131
2025
Q4 		$230K Buy
1,005
+40
+4% +$9.11K 0.07% 171
2025
Q3 		$236K Buy
+965
New +$197K 0.08% 158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WealthCare Investment Partners's ABBV Position: Q2 2026 in Review

WealthCare Investment Partners increased its AbbVie (ABBV) stake by 0.4% in Q2 2026, buying an estimated $1.72K and bringing the position to 2,020 shares worth $508K. The position accounts for 0.12% of the portfolio, ranked #126.

WealthCare Investment Partners first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WealthCare Investment Partners held 2,020 shares of AbbVie worth $508K as of Q2 2026.
  • WealthCare Investment Partners bought 8 AbbVie shares in Q2 2026, an estimated $1.72K.
  • AbbVie made up 0.12% of WealthCare Investment Partners's portfolio in Q2 2026, its #126 holding.
  • WealthCare Investment Partners first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WealthCare Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.